Smaller prostate size predicts high grade prostate cancer at final pathology

Journal of Urology

Volumn 184, Issue 3, 2010, Pages 930-937

  Newton, Mark R ^a   Phillips, Sharon ^b   Chang, Sam S ^b   Clark, Peter E ^b   Cookson, Michael S ^b   Davis, Rodney ^b   Fowke, Jay H ^b   Herrell, S Duke ^b   Baumgartner, Roxelyn ^b   Chan, Robert ^c   Mishra, Vineet ^d   Blume, Jeffrey D ^b   Smith Jr , Joseph A ^b   Barocas, Daniel A ^b  

^a UNIVERSITY OF IOWA   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

nomograms; organ size; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; CLASSIFICATION; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; RISK;

AGED; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK;

EID: 77956632215     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.04.082     Document Type: Article

References (30)

1. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215
2. A. Briganti, F.K. Chun, and N. Suardi Prostate volume and adverse prostate cancer features: fact not artifact Eur J Cancer 43 2007 2669
3. S.J. Freedland, W.B. Isaacs, and E.A. Platz Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study J Clin Oncol 23 2005 7546
4. G.S. Kulkarni, R. Al-Azab, and G. Lockwood Evidence for a biopsy derived grade artifact among larger prostate glands J Urol 175 2006 505
5. W. Kassouf, H. Nakanishi, and A. Ochiai Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies J Urol 178 2007 111
6. J.I. Epstein, J. Srigley, and D. Grignon Recommendations for the reporting of prostate carcinoma: Association of Directors of Anatomic and Surgical Pathology Am J Clin Pathol 129 2008 24
7. F.E. Harrell Jr Relaxing linearity assumption for continuous predictors Regression Modeling Strategies 2001 Springer-Verlag New York 16 26
8. N. Horton, and S. Lipsitz Multiple imputation in practice Am Stat 55 2001 244
9. M.S. Lucia, J.I. Epstein, and P.J. Goodman Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial J Natl Cancer Inst 99 2007 1375
10. M. Han, A.W. Partin, and C.R. Pound Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy The 15-year Johns Hopkins experience Urol Clin North Am 28 2001 555
11. T.M. Pisansky, M.J. Kahn, and G.M. Rasp A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma Cancer 79 1997 337
12. D.V. Makarov, B.J. Trock, and E.B. Humphreys Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 Urology 69 2007 1095
13. M.W. Kattan, J.A. Eastham, and A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766
14. F.J. Bianco Jr, K.N. Mallah, and R. Korets Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer Urology 69 2007 343
15. S. Shariat, P.I. Karakiewicz, and C.G. Roehrborn An updated catalog of prostate cancer predictive tools Cancer 113 2008 3075
16. G. Kulkarni, G. Lockwood, and A. Evans Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy Cancer 109 2007 2432
17. C.H. Bangma, M.J. Roobol, and E.W. Steyerberg Predictive models in diagnosing indolent cancer Cancer 115 2009 3100
18. Y. Goto, M. Ohori, and A. Arakawa Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies J Urol 156 1996 1059
19. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
20. E. Steyerberg, M. Roobol, and M. Kattan Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram J Urol 177 2007 107
21. A. Quan, J. Ciezki, and C. Reddy Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostate Urology 68 2006 1237
22. S. Lehrer, N.N. Stone, and R.G. Stock Prostate cancer in a large prostate is associated with a decreased prostate specific antigen failure rate after brachytherapy J Urol 173 2005 79
23. M. Roach, F. Waldman, and A. Pollack Predictive models in external beam radiotherapy for clinically localized prostate cancer Cancer 115 2009 3112
24. M.W. Kattan, M.J. Zelefsky, and P.A. Kupelian Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer J Clin Oncol 18 2000 3352
25. M.J. Zelefsky, O. Lyass, and Z. Fuks Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy J Clin Oncol 16 1998 3380
26. C.T. Nguyen, M.J. Zelefsky, and M.W. Kattan The current state of brachytherapy nomograms for patients with clinically localized prostate cancer Cancer 115 2009 3121
27. M.W. Kattan, L. Potters, and J.C. Blasko Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer Urology 58 2001 393
28. L. Potters, M. Roach 3rd, and B.J. Davis Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable Int J Radiat Oncol Biol Phys 76 2010 1061
29. F. Dong, J.S. Jones, and A.J. Stephenson Prostate cancer volume at biopsy predicts clinically significant upgrading J Urol 179 2008 896
30. A. Rahmouni, A. Yang, and C.M. Tempany Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography J Comput Assist Tomogr 16 1992 935